|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for IFIH1 |
 Gene summary |
| Basic gene Info. | Gene symbol | IFIH1 |
| Gene name | interferon induced with helicase C domain 1 | |
| Synonyms | AGS7|Hlcd|IDDM19|MDA-5|MDA5|RLR-2 | |
| Cytomap | UCSC genome browser: 2q24 | |
| Type of gene | protein-coding | |
| RefGenes | NM_022168.3, | |
| Description | CADM-140 autoantigenDEAD/H (Asp-Glu-Ala-Asp/His) box polypeptideRIG-I-like receptor 2RNA helicase-DEAD box protein 116clinically amyopathic dermatomyositis autoantigen 140 kDahelicardhelicase with 2 CARD domainsinterferon-induced helicase C domain- | |
| Modification date | 20141222 | |
| dbXrefs | MIM : 606951 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000115267 | ||
| HPRD : 09507 | ||
| Vega : OTTHUMG00000132055 | ||
| Protein | UniProt: Q9BYX4 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_IFIH1 | |
| BioGPS: 64135 | ||
| Pathway | NCI Pathway Interaction Database: IFIH1 | |
| KEGG: IFIH1 | ||
| REACTOME: IFIH1 | ||
| Pathway Commons: IFIH1 | ||
| Context | iHOP: IFIH1 | |
| ligand binding site mutation search in PubMed: IFIH1 | ||
| UCL Cancer Institute: IFIH1 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0016925 | protein sumoylation | 21156324 |
| Top |
| Ligand binding site mutations for IFIH1 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | T811 | T811A | BRCA | 1 | S760 | S760I | COAD | 1 | E924 | E924D | COAD | 1 | E924 | E924Q | LUAD | 1 | V791 | A792T | LUSC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for IFIH1 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | S760 | S760I | 0.67451643 | E924 | E924Q | -1.1125722 | T811 | T811A | -1.085941 | E924 | E924D | -1.0743659 | V791 | A792T | -0.30649378 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for IFIH1 from PDB |
| Top |
| Differential gene expression and gene-gene network for IFIH1 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for IFIH1 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0024141 | Lupus Erythematosus, Systemic | 12 | Biomarker, GeneticVariation |
| umls:C0018213 | Graves Disease | 4 | Biomarker, GeneticVariation |
| umls:C0033860 | Psoriasis | 3 | Biomarker, GeneticVariation |
| umls:C1857808 | Diabetes Mellitus, Insulin-Dependent, 19 | 2 | Biomarker, GeneticVariation |
| umls:C0796126 | Aicardi-Goutieres syndrome | 2 | Biomarker |
| umls:C0021400 | Influenza, Human | 2 | Biomarker |
| umls:C0162538 | IgA Deficiency | 1 | Biomarker, GeneticVariation |
| umls:C0042900 | Vitiligo | 1 | Biomarker |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for IFIH1 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of IFIH1 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NUC | Nucleic Acids | 4gl2 | B | S760 V791 E924 | NUC | Nucleic Acids | 4gl2 | A | T811 | NUC | Nucleic Acids | 4gl2 | B | T811 | NUC | Nucleic Acids | 4gl2 | A | V791 E924 |
| Top |
| Conservation information for LBS of IFIH1 |
| Multiple alignments for Q9BYX4 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |